A Possible Bidding War for Human Genome Sciences?


"Human Genome has set a July 16 deadline for takeover offers from suitors other than GlaxoSmithKline. Investors would likely react with horror and anger if Celgene were to make a run at Human Genome."

Seeking Alpha

Reuters announced late Friday, July 6, 2012, that an unnamed source said Celgene (CELG) may be mulling a bid for Human Genome Science, Inc. (HGSI). Late Sunday, July 8, 2012, The Street, also referencing an unnamed source, wrote, "Celgene has no interest in an acquisition of Human Genome or a merger of equals between the two companies, according to my source, contradicting the Reuters story. More likely, bankers working for Human Genome are planting speculative rumors in the press to compel Glaxo to raise its offer price, my source adds.". . .View Full Article

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe